Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study.
Use of mobile device technology to continuously collect patient-reported symptoms during radiation therapy for head and neck cancer: A prospective feasibility study.
复制标题
DOI：
10.1016/j.adro.2016.02.001
复制
发表时间：
2016-04-01
影响因子：
2.3
通讯作者：
Chera, Bhishamjit S
中科院分区：
文献类型：
--
作者：
Falchook, Aaron D;Tracton, Gregg;Chera, Bhishamjit S
目的：准确评估毒性，以便在头颈癌放射治疗期间及时提供支持措施。目前的模式需要提供者每周对患者进行评估。本研究的目的是评估通过移动设备监测患者报告症状的可行性。方法和材料：我们开发了一个移动应用程序，供患者使用验证性问题报告5个领域的症状。患者被要求在治疗期间每天使用一次移动设备报告症状，或者根据需要更频繁地报告症状。临床医生在每周的症状管理访问中审查了患者报告的症状，患者完成了关于移动应用程序效用的感知调查。主要的结果衡量标准是患者对移动设备报告的遵从性。依从性定义为症状报告的天数除以研究的天数。结果：在治疗过程中收集了22名患者的921份症状报告。报告遵从性的中位数为71%(四分位数范围为45%-80%)。每名患者提交的报告的中位数为34(四分位数范围为21-53)。在整个放射治疗期间，患者每周提交的报告的中位数是相似的，在非临床时间有显著的报告。患者对使用移动设备报告症状的满意度很高。结论：相当大比例的患者在头颈部癌症的放射治疗过程中使用移动设备连续报告症状。未来的研究应该评估移动设备症状报告对改善患者预后的影响。
PURPOSE: Accurate assessment of toxicity allows for timely delivery of supportive measures during radiation therapy for head and neck cancer. The current paradigm requires weekly evaluation of patients by a provider. The purpose of this study is to evaluate the feasibility of monitoring patient reported symptoms via mobile devices.METHODS AND MATERIALS: We developed a mobile application for patients to report symptoms in 5 domains using validated questions. Patients were asked to report symptoms using a mobile device once daily during treatment or more often as needed. Clinicians reviewed patient-reported symptoms during weekly symptom management visits and patients completed surveys regarding perceptions of the utility of the mobile application. The primary outcome measure was patient compliance with mobile device reporting. Compliance is defined as number of days with a symptom report divided by number of days on study.RESULTS: There were 921 symptom reports collected from 22 patients during treatment. Median reporting compliance was 71% (interquartile range, 45%-80%). Median number of reports submitted per patient was 34 (interquartile range, 21-53). Median number of reports submitted by patients per week was similar throughout radiation therapy and there was significant reporting during nonclinic hours. Patients reported high satisfaction with the use of mobile devices to report symptoms.CONCLUSIONS: A substantial percentage of patients used mobile devices to continuously report symptoms throughout a course of radiation therapy for head and neck cancer. Future studies should evaluate the impact of mobile device symptom reporting on improving patient outcomes.